NYSCF Press Releases
NYSCF has been at the forefront of bringing mitochondrial replacement therapy to the clinic and in 2011, published a seminal paper in Nature that showed mitochondrial replacement could be done successfully with human oocytes. Our scientists have been working since then to ensure this procedure would be safe and efficacious when brought…
After marking it's 10th Anniversary, NYSCF is excited to announce a 2016 move to the far west side after signing a multi-year lease for 42,000 square-feet at Taconic Partners LLC 619 West 54th Street. The 10-story, 333,000-square-foot Art Deco building will be the new home of the NYSCF offices and…
At The 2015 NYSCF Conference: Tenth Annual Translational Stem Cell Research Conference, NYSCF announced Franziska Michor. PhD, as the 2015 recipient of the Robertson Stem Cell Prize. Dr. Michor fuses her passions in mathematics, molecular biology and patient care to investigate how cancers form and progress. As a Professor of…
Five new NYSCF – Robertson Investigators join the prestigious community of early career scientists making the transition from post-doctoral research to their own labs. The three new 2015 NYSCF – Robertson Stem Cell Investigators, Mitchell Guttman, PhD, Justin Ichida, PhD, and Kristy Red-Horse, PhD, each receive funds to disbursed over…
At the 10th Annual NYSCF Conference on Translational Stem Cell Research NYSCF will bring together world leaders in biotechnology, regenerative medicine, precision medicine, and pharmaceuticals to address moving cures from research results to patients’ hands. This year, two nobel laureates will chair panels and participate in discussions on “Transformative Technologies”…
NYSCF and CBR Systems, Inc. DBA Cord Blood Registry (CBR) are collaborating to customize the creation of high-quality stem cell lines from umbilical cord blood tissue. NYSCF will create induced pluripotent stem (iPS) cell lines from umbilical cord tissue collected after birth from healthy newborns provided by CBR. The partnership…
NYSCF announces a new partnership with Q-State Biosciences (Q-State) to generate high quality stem cells from patient blood cells. The collaboration will mark the first time the generation of induced pluripotent stem (iPS) cells from blood cells will be automated with high-throughput massively parallel technology. The NYSCF Global Stem Cell…
NYSCF is committed to looking for novel ways to accelerate cures to the major diseases of our time through stem cell research. As an international organization promoting stem cell research worldwide, NYSCF announces that it now accepts philanthropic gifts in bitcoin. Bitcoin is the world’s preeminent digital currency. A non-government…
NYSCF designed and has built a revolutionary, high-throughput robotic platform that automates and standardizes the process of transforming patient samples into stem cells. This one-of-a-kind system addresses challenges that face the entire field, and is now an essential resource that NYSCF provides in collaborations with leading academic and industry partners…
NYSCF's Initiative on Women in Science and Engineering, or IWISE, brings together leading women and men in science, engineering and medicine to address gender equality in these fields.  Working towards this goal, the IWISE Working Group published a paper in Cell Stem Cell recommending seven actionable strategies for advancing women in science, engineering,…
Page 1 of 10
You are here: News Press Releases